Dieter Kraft
Managing Director @ TRUMPF Venture
Stuttgart, Germany
Dieter Kraft is a Series A investor at TRUMPF Venture in Stuttgart focused on Manufacturing and Health Care. Dieter Kraft, Investment Partner at RBVC, coordinates the European Venture Business of RBVC. Being with Bosch since 1990 Dieter holds contacts to the Bosch management organization and is broad based in technology. Before he joined RBVC in June 2009 he was heading the Systems engineering Division of Hybrid Electric- and Electric Vehicles withinBosch worldwide. Dieter’s professional background is operational business within Hardware / Software of automotive electronics and Software for telecommunication networks. Heading a Corporate Research Division he was in charge of communication and energy networks, Software methods and architectures, electric drives, human machine interaction and new business areas for Bosch. Dieter got his PhD at University of Frankfurt in nuclear and atomic physics and got some insights to mathematics, pharmacology and nuclear medicine during his studies.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Dieter Kraft invests in
Stages Dieter Kraft invests in
Countries Dieter Kraft invests in
Investment Focus
Industry
- Manufacturing 4 (33%)
- Health Care 3 (25%)
- Medical 2 (17%)
- Software 2 (17%)
- Electronics 2 (17%)
Stage
- Series A 3 (25%)
- Funding Round 3 (25%)
- Seed 2 (17%)
- Series B 2 (17%)
- Pre-Seed 1 (8%)
Country
- Germany 6 (50%)
- Norway 1 (8%)
- Finland 1 (8%)
- United States 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sensibel
|
Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology. | $16.1M / Series A / Apr 25, 2022 | |
Scrona AG
|
Scrona is an innovative start-up developing a novel ultrahigh-resolution inkjet technology based on electrostatic droplet actuation. With proprietary MEMS printheads, printing at the sub-micron level is possible, enabling additive, non-contact and digital industrial microfabrication. | $6.7M / Series A / Feb 15, 2022 | |
Kiutra
|
At kiutra, our mission is to provide our research and industry customers with easy-to-use, turn-key cryostats that give them the time to focus on their work rather than on their cryostats. We facilitate low-temperature investigations of material samples and accelerate the development and testing of quantum hardware and related electronics by meansof fast-cooling tools and innovative sample exchange mechanisms. Our cooling platforms offer continuous sub-Kelvin cooling independent of liquid cooling media, notably independent of rare and costly helium-3. This is essential to provide cryogenic temperatures in a simple, compact, and cost-efficient way, and a prerequisite for the application of quantum electronics, such used for quantum computing, quantum communications and quantum sensing at an industrial scale. | Nov 24, 2021 | |
|
Kiutra
|
At kiutra, our mission is to provide our research and industry customers with easy-to-use, turn-key cryostats that give them the time to focus on their work rather than on their cryostats. We facilitate low-temperature investigations of material samples and accelerate the development and testing of quantum hardware and related electronics by meansof fast-cooling tools and innovative sample exchange mechanisms. Our cooling platforms offer continuous sub-Kelvin cooling independent of liquid cooling media, notably independent of rare and costly helium-3. This is essential to provide cryogenic temperatures in a simple, compact, and cost-efficient way, and a prerequisite for the application of quantum electronics, such used for quantum computing, quantum communications and quantum sensing at an industrial scale. | Seed / Nov 24, 2021 | |
CYR3CON
|
CYR3CON predicts cyber-attacks through a suite of solutions using artificial intelligence. CYR3CON's methods leverage multiple sources of data from various online hacker communities to avoid many cyber incidents by quantifying and predicting hacker actions before they launch their attacks.The company was founded in 2018 and based in Tempe,Arizona. | $8.2M / Series A / Jul 14, 2020 | |
|
CYR3CON
|
CYR3CON predicts cyber-attacks through a suite of solutions using artificial intelligence. CYR3CON's methods leverage multiple sources of data from various online hacker communities to avoid many cyber incidents by quantifying and predicting hacker actions before they launch their attacks.The company was founded in 2018 and based in Tempe,Arizona. | Seed / Jan 20, 2020 | |
Peers Solutions
|
Peers is a AI based learning platform. Their USP are taylored learning paths, individualized and suited to a company’s strategy. | Pre-Seed / Nov 27, 2019 | |
Emperra
|
Emperra E-Health Technologies develops GSM and web based Tele-medical products for tracking, monitoring, and transmission of diagnostic and therapeutic data of diabetic patients such as insulin doses, blood sugar levels and carbohydrates. The company was founded in 2008 and is based in Potsdam, Germany. | $3M / Series B / Jan 04, 2016 | |
Optomed
|
Optomed Oy is a Finnish medical technology company that specializes in retinal imaging devices and solutions. Optomed’s mission is to make eye disease screenings available for everyone, wherever needed. We develop, commercialize and manufacture modern, mobile and easy-to-use retinal imaging devices that are suitable for any clinic for screening ofvarious eye diseases, such as diabetic retinopathy, glaucoma and AMD. Optomed’s hand-held fundus cameras fulfill international ISO 10940 fundus camera standard requirements and are being used by private clinics, public hospitals, non-government organizations and charities around the world. Optomed’s products are registered and marketed in all major markets: Europe, USA, China, Russia, Japan, Korea, India and Brazil.Optomed Oy (Ltd.) is a privately owned company with its headquarters based in Oulu, Finland. In addition, there are local offices in Shanghai (China) and in Espoo (Finland). | Oct 01, 2015 | |
GNA Biosolutions
|
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Theirvision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere. | $6.4M / Series B / Mar 07, 2015 | |
| See all 12 investments → | |||
Co-Investors
About TRUMPF Venture
The corporate venture capital arm TRUMPF Venture extends TRUMPF’s comprehensive activities to promote innovation and to detect disruptive technologies and business models early on. TRUMPF is the world technological and market leader for machine tools used in flexible sheet metal processing as well as industrial lasers. TRUMPF Venture investsglobally in early-stage start-ups active in areas complementary or adjacent to the TRUMPF core, such as Advances Photonics and Smart Factory. Funded start-ups benefit from an extensive network, deep domain knowhow, proven skills in scalability as well as support to access the TRUMPF group and its ecosystem. The requirements for a potential investment are a strategic fit, a high innovation leverage and differentiation in business model or technology, an experienced management team and risk adequate financial returns.
TRUMPF Venture Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ulrich Kruse
Investment Manager
|
|||
|
Dieter Kraft
Managing Director
|
|||
Jens Ortgiese
Principal
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dieter Kraft invest in?
Dieter Kraft invests primarily in Manufacturing, Health Care and Medical startups, most often at Series A and Funding Round stage. Most of the 12 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dieter Kraft last invest?
The most recent investment recorded for Dieter Kraft closed in Apr 2022. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
